Table 2.

Prevalence of biochemical endocrine abnormalities in the study cohort over four cycles.

Hormone	Number of patients with abnormal results / total number of patients
1. Adrenocorticotropic hormone	6/25 (24%)
2. Cortisol	5/25 (20%)
3. Thyroid stimulating hormone	5/24 (20.8%)
4. Free thyroxine	4/24 (16.7%)
5. Follicle stimulating hormone (males and postmenopausal females)	3/16 (18.8%)
6. Luteinizing hormone (males and postmenopausal females)	4/17 (23.5%)
7. Testosterone (males)	3/11 (27.3%)
8. Estradiol (premenopausal females)	3/5 (60%)
9. Growth hormone	4/26 (15.4%)
10. Prolactin	10/20 (50%)